Skip to main content
. 2024 Feb 5;2024(2):CD015219. doi: 10.1002/14651858.CD015219.pub2

4.9. Analysis.

4.9

Comparison 4: Sensitivity analysis (excluding studies with high risk of bias), Outcome 9: Serious adverse events attributable to the drug